Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / ACRS - Aclaris alopecia drug meets trial endpoint; shares -17%

ACRS - Aclaris alopecia drug meets trial endpoint; shares -17%

Aclaris Therapeutics Inc.
  • Aclaris Therapeutics (NASDAQ:ACRS) says that its Phase 2 trial of ATI-501 oral in patients with Alopecia Areata met its primary endpoint.
  • More news on: Aclaris Therapeutics, Inc., Healthcare stocks news, Stocks on the move,
    • Read more ...
Stock Information
Company Name: Aclaris Therapeutics Inc.
Stock Symbol: ACRS
Market: NASDAQ
Website: aclaristx.com
Menu
ACRS ACRS Quote ACRS Short ACRS News ACRS Articles ACRS Message Board
Get ACRS Alerts

News, Short Squeeze, Breakout and More Instantly...